Holmes will likely remain on the stand through Tuesday of next week, her lawyer said. Holmes' testimony lasted roughly an hour, ending around 4:10 p.m., when Judge Edward Davila said the court would be in recess until Monday.
#Blood in blood out full movie stream series#
Ellison ended up joining the Series C investment round, along with Lucas and his nephew, Chris Lucas, who was one of the investors called by the prosecution. Holmes said she later met Oracle founder Larry Ellison through Lucas. "He asked us to get an audit of our financials. Harry Potter and the Half-Blood Prince Soundtrack Music - Complete Song List Tunefind Watch Harry Potter and the Half-Blood Prince Movie Online Blu-rayor. "He hired a law firm to review our patents," Holmes said. He began a very comprehensive diligence process." "I was introduced to him by someone who had gone to college with my dad," she said. "I knew him as someone who focused on building great companies in the long term," she said, naming Oracle, National Semiconductor and Adobe as some of his investments. "Don Lucas was one of the early VCs in Silicon Valley," Holmes said. Holmes said she met Lucas when the company was raising its Series B financing round. Holmes on Friday was asked about Don Lucas, one of the company's earliest backers and the founder of Lucas Venture Group. Numerous investors took the stand on behalf of the prosecution, telling the jury they were duped by Holmes, who allegedly misled them on the capabilities of the technology and its traction in the market. Over the years, Holmes went on to raise more than $940 million from institutions and wealthy individuals, eventually reaching a valuation for the company of $9 billion. "I started with talking to my parents and they let me take the money they saved for me to go to college," Holmes said. "I had the opportunity to hire some of the people I was working for and with at Stanford."ĭowney asked Holmes how she financed the early days of the company. "We were prototyping," Holmes said, adding that the early team was trying to build components of the technology. She told jurors that she tried to raise some money, get a lab and hire scientists. She said she initially called the company Real-Time Cures and changed the name to Theranos in 2005. Holmes, keeping her eyes mostly focused on her lawyer and not looking at the roughly 50 other people in the room, walked through her background at Stanford and her decision to drop out and pursue her start-up idea. Holmes had told prospective investors and others that Theranos' proprietary technology could run 1,000 blood tests. Multiple company insiders, including whistleblower and former lab assistant Erika Cheung, testified that Theranos' devices couldn't run more than 12 different tests, which contradicted the company's statements. Downey asked Holmes about her public pronouncements regarding how many tests Theranos could run and whether she was limiting her comments to certain types of tests.